(Q74650765)
English
A randomized multicenter trial of the anti-ICAM-1 monoclonal antibody (enlimomab) for the prevention of acute rejection and delayed onset of graft function in cadaveric renal transplantation: a report of the European Anti-ICAM-1 Renal Transplant Stu
scientific article published on 01 March 1999
Statements
A randomized multicenter trial of the anti-ICAM-1 monoclonal antibody (enlimomab) for the prevention of acute rejection and delayed onset of graft function in cadaveric renal transplantation: a report of the European Anti-ICAM-1 Renal Transplant Study Group (English)
K Salmela
L Wramner
H Ekberg
I Hauser
O Bentdal
L E Lins
H Isoniemi
L Bäckman
N Persson
H H Neumayer
P F Jørgensen
C Spieker
B Hendry
A Nicholls
G Kirste
1 March 1999